Credit Suisse Ag Essa Pharma Inc. Call Options Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EPIX
# of Institutions
36Shares Held
35MCall Options Held
53.4KPut Options Held
29.4K-
Bvf Inc San Francisco, CA8.75MShares$41.8 Million2.22% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.89MShares$37.7 Million1.05% of portfolio
-
Morgan Stanley New York, NY4.18MShares$20 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.59MShares$17.2 Million2.49% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.98MShares$14.2 Million1.25% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $211M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...